ENOXAPARIN SODIUM

ENOXAPARIN SODIUM was reported 58047 times

ENOXAPARIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABDOMINAL HAEMATOMA 47 0.2749
1 TRUNCUS ARTERIOSUS PERSISTENT 41 0.2060
2 AMAUROSIS FUGAX 215 0.1996
3 PELVIC HAEMATOMA 71 0.1610
4 RETROPERITONEAL HAEMORRHAGE 342 0.1385
5 HAEMATOMA MUSCLE 166 0.1384
6 ABDOMINAL WALL HAEMATOMA 263 0.1347
7 HEPARIN-INDUCED THROMBOCYTOPENIA 651 0.1320
8 RETROPERITONEAL HAEMATOMA 290 0.1311
9 DEVICE SAFETY FEATURE ISSUE 124 0.1258
10 INTRA-ABDOMINAL HAEMATOMA 153 0.1234
11 THROMBOCYTHAEMIA 63 0.1135
12 MIXED LIVER INJURY 211 0.0701
13 SHOCK HAEMORRHAGIC 570 0.0699
14 SPONTANEOUS HAEMATOMA 50 0.0669
15 MUSCLE HAEMORRHAGE 268 0.0667
16 CARDIAC SEPTAL DEFECT 41 0.0570
17 PROTHROMBIN TIME ABNORMAL 39 0.0564
18 EXTRADURAL HAEMATOMA 74 0.0559
19 VASCULAR PURPURA 73 0.0523
20 HAEMORRHAGIC STROKE 407 0.0521
21 HEPATIC CYTOLYSIS 649 0.0509
22 INTERNATIONAL NORMALISED RATIO DECREASED 204 0.0503
23 PERITONEAL HAEMORRHAGE 68 0.0490
24 CONGENITAL CARDIOVASCULAR ANOMALY 39 0.0465
25 HEPATOCELLULAR INJURY 655 0.0462
26 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 352 0.0453
27 POST PROCEDURAL HAEMATOMA 73 0.0432
28 HAEMATOMA 1117 0.0431
29 STREPTOCOCCAL SEPSIS 51 0.0430
30 ARTERIAL HAEMORRHAGE 49 0.0429
31 INTRA-ABDOMINAL HAEMORRHAGE 102 0.0428
32 URINARY TRACT DISORDER 190 0.0421
33 CHOLESTASIS 786 0.0409
34 RASH MORBILLIFORM 106 0.0382
35 VASCULAR PSEUDOANEURYSM 66 0.0379
36 JUGULAR VEIN THROMBOSIS 65 0.0365
37 COAGULATION TIME PROLONGED 56 0.0362
38 SUBCUTANEOUS HAEMATOMA 46 0.0360
39 CYTOLYTIC HEPATITIS 119 0.0358
40 EOSINOPHILIA 627 0.0357
41 HAEMORRHAGIC TRANSFORMATION STROKE 53 0.0352
42 HYPERCOAGULATION 67 0.0352
43 PSEUDOMONAL SEPSIS 61 0.0348
44 COMPARTMENT SYNDROME 89 0.0341
45 RASH MACULO-PAPULAR 738 0.0331
46 CEREBRAL HAEMATOMA 111 0.0330
47 VASCULAR DEVICE INFECTION 149 0.0328
48 CHOLESTATIC LIVER INJURY 73 0.0328
49 HYPOVOLAEMIC SHOCK 157 0.0327
50 INTERNATIONAL NORMALISED RATIO ABNORMAL 112 0.0325
51 TOXIC SKIN ERUPTION 308 0.0305
52 BLOOD LOSS ANAEMIA 69 0.0304
53 CELL DEATH 58 0.0292
54 PROTHROMBIN TIME PROLONGED 171 0.0286
55 OSTEOLYSIS 58 0.0283
56 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 143 0.0282
57 PARAPLEGIA 81 0.0280
58 VENA CAVA THROMBOSIS 46 0.0277
59 SPLENIC INFARCTION 48 0.0275
60 INJURY ASSOCIATED WITH DEVICE 546 0.0268
61 FOETAL GROWTH RESTRICTION 160 0.0263
62 AGRANULOCYTOSIS 486 0.0261
63 HEPATITIS CHOLESTATIC 157 0.0260
64 ECCHYMOSIS 178 0.0259
65 GENERALISED OEDEMA 314 0.0253
66 ANTIPHOSPHOLIPID SYNDROME 40 0.0249
67 VENOUS THROMBOSIS LIMB 50 0.0242
68 BICYTOPENIA 47 0.0240
69 CORONARY ARTERY THROMBOSIS 47 0.0233
70 KLEBSIELLA INFECTION 117 0.0231
71 DEEP VEIN THROMBOSIS 1502 0.0231
72 DUODENAL ULCER HAEMORRHAGE 66 0.0230
73 CLEFT PALATE 44 0.0228
74 INTRAVENTRICULAR HAEMORRHAGE 56 0.0225
75 HAEMATURIA 766 0.0223
76 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 572 0.0222
77 AORTIC ARTERIOSCLEROSIS 57 0.0221
78 LOBAR PNEUMONIA 41 0.0221
79 OVARIAN HYPERSTIMULATION SYNDROME 51 0.0219
80 HAEMORRHAGIC ANAEMIA 96 0.0218
81 INTERNATIONAL NORMALISED RATIO INCREASED 622 0.0218
82 INTERNATIONAL NORMALISED RATIO FLUCTUATION 45 0.0217
83 HAEMOTHORAX 63 0.0217
84 ATELECTASIS 208 0.0215
85 SKIN NECROSIS 111 0.0214
86 LOW BIRTH WEIGHT BABY 170 0.0214
87 DEVICE RELATED SEPSIS 43 0.0213
88 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 69 0.0212
89 VENOUS THROMBOSIS 83 0.0211
90 HEPATITIS ACUTE 135 0.0208
91 EMBOLISM 171 0.0206
92 THROMBOCYTOSIS 75 0.0204
93 FIBRIN D DIMER INCREASED 72 0.0202
94 ABDOMINAL MASS 54 0.0201
95 THROMBOSIS IN DEVICE 66 0.0201
96 PURPURA 178 0.0201
97 PANCREATIC CARCINOMA METASTATIC 57 0.0200
98 HAEMATEMESIS 508 0.0200
99 INTRACARDIAC THROMBUS 61 0.0199
100 LEFT VENTRICULAR HYPERTROPHY 85 0.0198
101 DERMATITIS EXFOLIATIVE GENERALISED 69 0.0198
102 PHLEBITIS 101 0.0197
103 OCULAR DISCOMFORT 217 0.0193
104 PULMONARY EMBOLISM 1829 0.0192
105 CATHETER SITE HAEMORRHAGE 48 0.0192
106 MEAN CELL VOLUME INCREASED 49 0.0191
107 SUBDURAL HAEMATOMA 273 0.0191
108 THROMBOCYTOPENIA 2131 0.0190
109 METABOLIC ENCEPHALOPATHY 57 0.0190
110 HAEMATOCRIT DECREASED 376 0.0189
111 PERICARDIAL HAEMORRHAGE 41 0.0187
112 HYPERCAPNIA 56 0.0186
113 NEUROLOGICAL DECOMPENSATION 43 0.0186
114 NEPHROGENIC ANAEMIA 86 0.0185
115 PERIPHERAL ISCHAEMIA 75 0.0183
116 ERYSIPELAS 91 0.0181
117 THROMBOPHLEBITIS SUPERFICIAL 54 0.0178
118 DIASTOLIC DYSFUNCTION 55 0.0178
119 ORTHOPNOEA 56 0.0176
120 TOXIC EPIDERMAL NECROLYSIS 267 0.0176
121 TRICUSPID VALVE INCOMPETENCE 139 0.0175
122 CREATININE RENAL CLEARANCE DECREASED 70 0.0175
123 POST PROCEDURAL HAEMORRHAGE 203 0.0174
124 MITRAL VALVE INCOMPETENCE 195 0.0172
125 RENAL FAILURE ACUTE 731 0.0172
126 COAGULOPATHY 285 0.0171
127 OLIGURIA 106 0.0171
128 HAEMORRHAGE INTRACRANIAL 254 0.0170
129 ALTERED STATE OF CONSCIOUSNESS 368 0.0170
130 NORMOCHROMIC NORMOCYTIC ANAEMIA 51 0.0170
131 ENTEROCOCCAL INFECTION 81 0.0167
132 BRAIN HERNIATION 50 0.0167
133 MULTI-ORGAN FAILURE 287 0.0166
134 THROMBOPHLEBITIS 58 0.0165
135 PULMONARY INFARCTION 39 0.0165
136 FEBRILE BONE MARROW APLASIA 70 0.0165
137 BLOOD BLISTER 51 0.0163
138 BILIRUBIN CONJUGATED INCREASED 38 0.0162
139 CARDIAC TAMPONADE 76 0.0160
140 DERMATITIS BULLOUS 115 0.0159
141 SPINAL OSTEOARTHRITIS 139 0.0158
142 DERMATITIS EXFOLIATIVE 79 0.0158
143 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 60 0.0157
144 UPPER GASTROINTESTINAL HAEMORRHAGE 260 0.0154
145 CARDIO-RESPIRATORY ARREST 638 0.0152
146 BONE LESION 55 0.0152
147 ABDOMINAL TENDERNESS 75 0.0151
148 WOUND DEHISCENCE 51 0.0151
149 MULTIPLE MYELOMA 70 0.0150
150 ASCITES 438 0.0149
151 MELAENA 327 0.0148
152 CARDIOMEGALY 182 0.0148
153 HEART DISEASE CONGENITAL 52 0.0147
154 PULMONARY THROMBOSIS 160 0.0147
155 MULTIPLE INJURIES 92 0.0146
156 DECUBITUS ULCER 119 0.0146
157 EOSINOPHILIC PNEUMONIA 46 0.0146
158 BRAIN NATRIURETIC PEPTIDE INCREASED 45 0.0146
159 PREMATURE BABY 439 0.0146
160 LEFT VENTRICULAR DYSFUNCTION 97 0.0145
161 LOWER GASTROINTESTINAL HAEMORRHAGE 107 0.0145
162 HYPOXIA 509 0.0144
163 SPINAL CORD COMPRESSION 56 0.0144
164 BLOOD ALBUMIN DECREASED 114 0.0144
165 BLOOD CREATININE DECREASED 45 0.0144
166 INTESTINAL ISCHAEMIA 79 0.0143
167 PROTEIN TOTAL DECREASED 54 0.0143
168 HAEMODYNAMIC INSTABILITY 109 0.0143
169 ACUTE RESPIRATORY FAILURE 275 0.0143
170 CUTANEOUS VASCULITIS 52 0.0142
171 PATHOLOGICAL FRACTURE 72 0.0142
172 GAMMA-GLUTAMYLTRANSFERASE INCREASED 312 0.0141
173 LYMPHOPENIA 199 0.0141
174 LUNG INFILTRATION 124 0.0140
175 STAPHYLOCOCCAL BACTERAEMIA 61 0.0140
176 CAROTID ARTERY STENOSIS 49 0.0140
177 BLOOD CULTURE POSITIVE 42 0.0140
178 RESPIRATORY ACIDOSIS 55 0.0140
179 PREMATURE DELIVERY 222 0.0139
180 HEPATITIS FULMINANT 41 0.0138
181 VENTRICULAR SEPTAL DEFECT 79 0.0138
182 ATRIAL FLUTTER 110 0.0138
183 PSEUDOMONAS INFECTION 118 0.0137
184 DIVERTICULUM INTESTINAL 60 0.0137
185 CHEST X-RAY ABNORMAL 42 0.0137
186 THROMBOSIS 1102 0.0137
187 HYPERTRANSAMINASAEMIA 95 0.0136
188 BENIGN PROSTATIC HYPERPLASIA 70 0.0135
189 PETECHIAE 141 0.0135
190 JAUNDICE CHOLESTATIC 47 0.0133
191 CLOSTRIDIAL INFECTION 45 0.0133
192 CEREBRAL ATROPHY 53 0.0133
193 HAEMOPTYSIS 370 0.0133
194 ISCHAEMIC STROKE 235 0.0132
195 AORTIC VALVE INCOMPETENCE 56 0.0131
196 HYPOVOLAEMIA 77 0.0131
197 MALNUTRITION 147 0.0131
198 RENAL FAILURE CHRONIC 101 0.0131
199 ESCHERICHIA SEPSIS 38 0.0131
200 FAILURE TO THRIVE 68 0.0131
201 RENAL TUBULAR NECROSIS 128 0.0130
202 HEAD DISCOMFORT 231 0.0130
203 INJECTION SITE HAEMATOMA 189 0.0130
204 HYPOKALAEMIA 598 0.0129
205 PRESYNCOPE 315 0.0129
206 ESCHERICHIA URINARY TRACT INFECTION 55 0.0129
207 PULMONARY HAEMORRHAGE 101 0.0129
208 HYPERTHERMIA 98 0.0128
209 CEREBRAL ISCHAEMIA 66 0.0128
210 LEUKOCYTOSIS 231 0.0128
211 STAPHYLOCOCCAL SEPSIS 63 0.0127
212 RALES 74 0.0127
213 SUPRAVENTRICULAR EXTRASYSTOLES 43 0.0127
214 DUODENITIS 39 0.0127
215 CEREBRAL HAEMORRHAGE 455 0.0127
216 EXPOSURE DURING PREGNANCY 786 0.0126
217 AORTIC STENOSIS 44 0.0126
218 ENCEPHALOPATHY 306 0.0124
219 HUMERUS FRACTURE 60 0.0124
220 PANCYTOPENIA 695 0.0124
221 DYSAESTHESIA 38 0.0124
222 FEMORAL NECK FRACTURE 63 0.0123
223 HAEMOLYTIC ANAEMIA 110 0.0123
224 NECROSIS 68 0.0122
225 PLEURAL EFFUSION 742 0.0122
226 ACUTE PULMONARY OEDEMA 68 0.0121
227 LEUKOPENIA 606 0.0121
228 ANURIA 104 0.0121
229 RASH PUSTULAR 88 0.0121
230 HEPATIC CYST 41 0.0121
231 FLANK PAIN 113 0.0120
232 TOXIC ENCEPHALOPATHY 61 0.0120
233 PREMATURE LABOUR 67 0.0118
234 ANAEMIA 2259 0.0118
235 COMA 564 0.0118
236 BUNDLE BRANCH BLOCK LEFT 50 0.0118
237 BUNDLE BRANCH BLOCK RIGHT 54 0.0118
238 INTRACRANIAL PRESSURE INCREASED 65 0.0117
239 HAEMOGLOBIN DECREASED 1196 0.0116
240 VARICOSE VEIN 60 0.0116
241 METASTASES TO SPINE 39 0.0116
242 BLOOD ALKALINE PHOSPHATASE INCREASED 288 0.0116
243 TROPONIN INCREASED 88 0.0116
244 BREATH SOUNDS ABNORMAL 57 0.0115
245 SEPSIS 1288 0.0115
246 RESPIRATORY DISTRESS 318 0.0115
247 TRANSAMINASES INCREASED 254 0.0114
248 SINUS TACHYCARDIA 162 0.0114
249 ACIDOSIS 87 0.0114
250 BACTERAEMIA 135 0.0114
251 GASTROINTESTINAL HAEMORRHAGE 950 0.0114
252 HYPOALBUMINAEMIA 88 0.0113
253 HYPERLIPIDAEMIA 135 0.0113
254 SMALL FOR DATES BABY 56 0.0113
255 CONGESTIVE CARDIOMYOPATHY 47 0.0113
256 AZOTAEMIA 45 0.0113
257 HYPERNATRAEMIA 56 0.0112
258 SEPTIC SHOCK 489 0.0112
259 WOUND SECRETION 44 0.0112
260 HYDRONEPHROSIS 84 0.0112
261 CANDIDIASIS 45 0.0112
262 BRONCHOPNEUMONIA 38 0.0111
263 SUBARACHNOID HAEMORRHAGE 113 0.0111
264 HYPERKALAEMIA 389 0.0111
265 INGUINAL HERNIA 67 0.0110
266 FOETAL DEATH 57 0.0110
267 LYMPHOEDEMA 76 0.0110
268 ACUTE CORONARY SYNDROME 91 0.0110
269 FAECALOMA 60 0.0109
270 HEPATITIS 280 0.0109
271 PRE-ECLAMPSIA 52 0.0109
272 ISCHAEMIA 50 0.0109
273 CARDIOGENIC SHOCK 156 0.0109
274 HEPATIC LESION 47 0.0109
275 HYPERBILIRUBINAEMIA 112 0.0108
276 MYOCARDIAL ISCHAEMIA 123 0.0108
277 CLOSTRIDIUM DIFFICILE COLITIS 114 0.0107
278 TACHYPNOEA 145 0.0107
279 DUODENAL ULCER 75 0.0106
280 VENTRICULAR FIBRILLATION 118 0.0106
281 ACUTE KIDNEY INJURY 1621 0.0106
282 ECONOMIC PROBLEM 160 0.0105
283 DEVICE RELATED INFECTION 161 0.0104
284 RESPIRATORY FAILURE 760 0.0104
285 BRAIN OEDEMA 131 0.0104
286 ESCHERICHIA INFECTION 85 0.0103
287 RENAL CYST 82 0.0103
288 PERIPHERAL VASCULAR DISORDER 53 0.0103
289 HYPOPHOSPHATAEMIA 76 0.0103
290 HAEMORRHAGE 1073 0.0103
291 PARONYCHIA 45 0.0102
292 RECTAL HAEMORRHAGE 439 0.0102
293 MENTAL STATUS CHANGES 283 0.0102
294 CORONARY ARTERY STENOSIS 51 0.0101
295 MONOPLEGIA 44 0.0101
296 VENTRICULAR TACHYCARDIA 167 0.0101
297 TACHYCARDIA 897 0.0101
298 IRON DEFICIENCY ANAEMIA 93 0.0101
299 DISSEMINATED INTRAVASCULAR COAGULATION 141 0.0100
300 IRON DEFICIENCY 45 0.0100
301 PULMONARY ALVEOLAR HAEMORRHAGE 56 0.0100
302 ABDOMINAL ABSCESS 44 0.0099
303 DRUG EXPOSURE DURING PREGNANCY 338 0.0099
304 NEUTROPENIA 1345 0.0099
305 ACUTE RESPIRATORY DISTRESS SYNDROME 174 0.0098
306 OCCUPATIONAL EXPOSURE TO PRODUCT 63 0.0098
307 LARGE INTESTINE PERFORATION 68 0.0098
308 UROSEPSIS 90 0.0097
309 PULMONARY HYPERTENSION 203 0.0097
310 INJECTION SITE NODULE 107 0.0097
311 ORGAN FAILURE 39 0.0097
312 ARTERIOSCLEROSIS 91 0.0097
313 GASTRITIS EROSIVE 45 0.0096
314 INTERNAL HAEMORRHAGE 110 0.0096
315 PHOTOPHOBIA 181 0.0096
316 COVID-19 PNEUMONIA 113 0.0096
317 ABORTION INDUCED 90 0.0095
318 ANGINA UNSTABLE 62 0.0095
319 COMPRESSION FRACTURE 51 0.0095
320 SMALL INTESTINAL OBSTRUCTION 117 0.0095
321 REFUSAL OF TREATMENT BY PATIENT 62 0.0095
322 ATRIOVENTRICULAR BLOCK FIRST DEGREE 41 0.0094
323 DYSLIPIDAEMIA 48 0.0094
324 ATRIAL FIBRILLATION 919 0.0094
325 HYPONATRAEMIA 531 0.0094
326 FEBRILE NEUTROPENIA 623 0.0094
327 ABSCESS LIMB 40 0.0094
328 FAECAL INCONTINENCE 45 0.0094
329 HAEMOLYSIS 72 0.0093
330 BLOOD UREA INCREASED 156 0.0093
331 MOUTH HAEMORRHAGE 68 0.0093
332 PYELONEPHRITIS 80 0.0092
333 HYPERTRIGLYCERIDAEMIA 54 0.0092
334 SINUS BRADYCARDIA 89 0.0092
335 LIVE BIRTH 77 0.0092
336 CARDIAC FAILURE ACUTE 61 0.0091
337 CACHEXIA 47 0.0091
338 SUPRAVENTRICULAR TACHYCARDIA 87 0.0091
339 MATERNAL EXPOSURE DURING PREGNANCY 808 0.0091
340 PULSE ABSENT 43 0.0090
341 METASTASES TO LYMPH NODES 61 0.0090
342 GESTATIONAL DIABETES 43 0.0090
343 GASTRIC ULCER HAEMORRHAGE 50 0.0090
344 DIVERTICULUM 64 0.0090
345 LIPASE INCREASED 69 0.0090
346 NEUTROPHIL COUNT INCREASED 92 0.0090
347 BLOOD CALCIUM DECREASED 101 0.0090
348 CYTOKINE RELEASE SYNDROME 180 0.0090
349 PULMONARY CONGESTION 118 0.0089
350 CORONARY ARTERY DISEASE 271 0.0089
351 CYANOSIS 140 0.0089
352 CARDIAC MURMUR 76 0.0088
353 TRANSFUSION 92 0.0088
354 ENDOCARDITIS 45 0.0088
355 TUMOUR LYSIS SYNDROME 77 0.0087
356 HYPOMAGNESAEMIA 121 0.0087
357 ASPARTATE AMINOTRANSFERASE INCREASED 461 0.0087
358 DIPLOPIA 224 0.0086
359 METASTASES TO CENTRAL NERVOUS SYSTEM 111 0.0086
360 PERICARDIAL EFFUSION 198 0.0086
361 RENAL FAILURE 1135 0.0085
362 TIBIA FRACTURE 40 0.0085
363 ACUTE MYOCARDIAL INFARCTION 250 0.0085
364 DEVICE MALFUNCTION 594 0.0084
365 ARTERIOSCLEROSIS CORONARY ARTERY 56 0.0084
366 C-REACTIVE PROTEIN INCREASED 307 0.0084
367 POLYNEUROPATHY 101 0.0084
368 MYOCLONUS 100 0.0084
369 POST PROCEDURAL COMPLICATION 161 0.0084
370 VENTRICULAR EXTRASYSTOLES 87 0.0084
371 ATRIOVENTRICULAR BLOCK COMPLETE 56 0.0084
372 URINE OUTPUT DECREASED 73 0.0083
373 BLOOD LACTATE DEHYDROGENASE INCREASED 132 0.0083
374 NEPHROTIC SYNDROME 57 0.0083
375 SPLENOMEGALY 95 0.0081
376 HIATUS HERNIA 105 0.0081
377 HYPERVOLAEMIA 40 0.0081
378 GROIN PAIN 71 0.0081
379 FOETAL EXPOSURE DURING PREGNANCY 656 0.0081
380 EJECTION FRACTION DECREASED 125 0.0080
381 HYPOCALCAEMIA 152 0.0080
382 TENDERNESS 83 0.0080
383 SUDDEN DEATH 84 0.0079
384 BLOOD BILIRUBIN INCREASED 214 0.0079
385 ALANINE AMINOTRANSFERASE INCREASED 486 0.0079
386 EPISTAXIS 592 0.0079
387 HEMIPARESIS 134 0.0079
388 GASTRIC HAEMORRHAGE 91 0.0079
389 OESOPHAGITIS 86 0.0079
390 ABORTION SPONTANEOUS 313 0.0078
391 NEEDLE ISSUE 227 0.0078
392 STATUS EPILEPTICUS 88 0.0078
393 UNRESPONSIVE TO STIMULI 200 0.0077
394 ADRENAL INSUFFICIENCY 94 0.0077
395 ANHEDONIA 203 0.0077
396 ERYTHEMA MULTIFORME 72 0.0077
397 LIVER FUNCTION TEST ABNORMAL 224 0.0077
398 METASTASES TO BONE 126 0.0077
399 STAPHYLOCOCCAL INFECTION 253 0.0077
400 HYPOTENSION 1537 0.0077
401 SYRINGE ISSUE 132 0.0075
402 HERPES SIMPLEX 49 0.0075
403 CHOLECYSTITIS 89 0.0075
404 GANGRENE 45 0.0075
405 MATERNAL EXPOSURE BEFORE PREGNANCY 51 0.0075
406 HAEMOGLOBIN ABNORMAL 48 0.0075
407 HEMIPLEGIA 62 0.0074
408 RIGHT VENTRICULAR FAILURE 52 0.0074
409 HAEMARTHROSIS 66 0.0074
410 PERIPHERAL SENSORY NEUROPATHY 43 0.0073
411 BRONCHOPULMONARY ASPERGILLOSIS 57 0.0073
412 CARDIAC VALVE DISEASE 42 0.0073
413 HYDROCEPHALUS 40 0.0073
414 BLOOD CREATININE INCREASED 479 0.0073
415 PNEUMOTHORAX 116 0.0073
416 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 75 0.0073
417 HEPATIC STEATOSIS 136 0.0073
418 CAESAREAN SECTION 85 0.0073
419 PNEUMONIA ASPIRATION 182 0.0073
420 HAEMODIALYSIS 61 0.0073
421 PULMONARY OEDEMA 325 0.0073
422 HYPERVENTILATION 42 0.0072
423 CIRCULATORY COLLAPSE 123 0.0072
424 OEDEMA PERIPHERAL 879 0.0072
425 HYPERCALCAEMIA 89 0.0072
426 STREPTOCOCCAL INFECTION 40 0.0072
427 CELLULITIS 361 0.0072
428 METABOLIC ACIDOSIS 229 0.0072
429 OBESITY 114 0.0071
430 FEAR 192 0.0071
431 LYMPHOCYTE COUNT DECREASED 126 0.0071
432 BLOOD DISORDER 57 0.0071
433 HALLUCINATION, VISUAL 150 0.0071
434 PNEUMONITIS 193 0.0071
435 ILEUS 88 0.0071
436 RENAL INJURY 210 0.0071
437 MULTIPLE ORGAN DYSFUNCTION SYNDROME 200 0.0071
438 GRAND MAL CONVULSION 65 0.0070
439 ASPIRATION 77 0.0070
440 GASTRITIS 185 0.0070
441 DRUG INTERACTION 1114 0.0070
442 STEVENS-JOHNSON SYNDROME 156 0.0070
443 PLATELET COUNT DECREASED 745 0.0070
444 PNEUMONIA BACTERIAL 64 0.0070
445 CARDIOMYOPATHY 103 0.0070
446 SHOCK 160 0.0069
447 RESPIRATORY RATE INCREASED 61 0.0069
448 SYNCOPE 685 0.0068
449 SENSORY LOSS 55 0.0068
450 PLATELET COUNT ABNORMAL 41 0.0068
451 WOUND INFECTION 74 0.0068
452 TORSADE DE POINTES 53 0.0067
453 HEPATIC ENCEPHALOPATHY 63 0.0067
454 CONTUSION 649 0.0067
455 EMPHYSEMA 68 0.0067
456 PANCREATITIS ACUTE 151 0.0067
457 INTERVERTEBRAL DISC DEGENERATION 62 0.0067
458 BLINDNESS 273 0.0067
459 GENERAL PHYSICAL HEALTH DETERIORATION 774 0.0067
460 RED BLOOD CELL COUNT DECREASED 191 0.0067
461 LUNG DISORDER 327 0.0067
462 TUBULOINTERSTITIAL NEPHRITIS 125 0.0067
463 POSTOPERATIVE WOUND INFECTION 45 0.0067
464 SPINAL COMPRESSION FRACTURE 55 0.0066
465 ELECTROLYTE IMBALANCE 77 0.0066
466 URINARY RETENTION 221 0.0066
467 JAUNDICE 178 0.0066
468 CARDIAC FAILURE CONGESTIVE 531 0.0066
469 INJECTION SITE BRUISING 527 0.0066
470 DEHYDRATION 880 0.0066
471 OSTEOPENIA 100 0.0066
472 BRADYCARDIA 349 0.0066
473 ATRIOVENTRICULAR BLOCK 50 0.0065
474 NEUTROPENIC SEPSIS 46 0.0064
475 METASTASES TO LIVER 113 0.0064
476 METASTASES TO LUNG 74 0.0064
477 NEUTROPHIL COUNT DECREASED 260 0.0064
478 GASTRIC ULCER 121 0.0064
479 END STAGE RENAL DISEASE 116 0.0064
480 CARDIAC ARREST 524 0.0063
481 BODY TEMPERATURE INCREASED 129 0.0063
482 OXYGEN SATURATION DECREASED 355 0.0063
483 ELECTROCARDIOGRAM QT PROLONGED 227 0.0063
484 WHITE BLOOD CELL COUNT INCREASED 242 0.0063
485 PLATELET COUNT INCREASED 82 0.0063
486 FACE OEDEMA 106 0.0063
487 TRANSIENT ISCHAEMIC ATTACK 212 0.0063
488 PROCEDURAL COMPLICATION 48 0.0063
489 JOINT EFFUSION 43 0.0062
490 DYSPNOEA EXERTIONAL 234 0.0062
491 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 59 0.0062
492 CHOLELITHIASIS 202 0.0062
493 CANDIDA INFECTION 104 0.0062
494 GINGIVAL BLEEDING 84 0.0061
495 MATERNAL DRUGS AFFECTING FOETUS 47 0.0061
496 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
497 LUNG INFECTION 95 0.0061
498 HEPATIC FAILURE 184 0.0061
499 PYREXIA 2098 0.0061
500 SLEEP APNOEA SYNDROME 115 0.0060
501 EOSINOPHIL COUNT INCREASED 50 0.0060
502 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 45 0.0060
503 MOTOR DYSFUNCTION 61 0.0060
504 HYPERGLYCAEMIA 217 0.0059
505 INJURY 418 0.0059
506 COLITIS ISCHAEMIC 40 0.0059
507 HEPATOMEGALY 58 0.0059
508 OSTEOMYELITIS 106 0.0058
509 CONFUSIONAL STATE 946 0.0058
510 BLOOD MAGNESIUM DECREASED 50 0.0058
511 ABSCESS 92 0.0058
512 ABDOMINAL PAIN 1338 0.0057
513 THROMBOTIC MICROANGIOPATHY 56 0.0057
514 ATRIAL SEPTAL DEFECT 48 0.0057
515 APHASIA 173 0.0057
516 DISORIENTATION 226 0.0057
517 MUSCULOSKELETAL CHEST PAIN 88 0.0057
518 APNOEA 44 0.0056
519 LYMPHADENOPATHY 199 0.0056
520 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 293 0.0056
521 PALLOR 151 0.0055
522 CHILLS 649 0.0055
523 POLYURIA 45 0.0055
524 MYOSITIS 49 0.0055
525 CARDIAC FAILURE 438 0.0055
526 DELIRIUM 189 0.0054
527 INJECTION SITE DISCOLOURATION 68 0.0054
528 FLUID OVERLOAD 79 0.0054
529 MIOSIS 43 0.0054
530 INTESTINAL PERFORATION 60 0.0053
531 HYPOGLYCAEMIA 259 0.0053
532 PNEUMONIA 1716 0.0053
533 AORTIC ANEURYSM 40 0.0053
534 RASH ERYTHEMATOUS 251 0.0052
535 HICCUPS 43 0.0052
536 MYOCARDITIS 60 0.0052
537 RENAL IMPAIRMENT 439 0.0052
538 GLOMERULAR FILTRATION RATE DECREASED 64 0.0052
539 FEMUR FRACTURE 161 0.0052
540 COLITIS 197 0.0052
541 HYPERTHYROIDISM 75 0.0052
542 BLOOD PRESSURE DECREASED 340 0.0051
543 BRONCHOSPASM 73 0.0051
544 TINNITUS 235 0.0051
545 INJECTION SITE MASS 189 0.0051
546 ORTHOSTATIC HYPOTENSION 89 0.0051
547 JOINT DISLOCATION 54 0.0051
548 OSTEONECROSIS OF JAW 126 0.0051
549 OEDEMA 276 0.0051
550 IMPAIRED HEALING 167 0.0051
551 HYPERCHOLESTEROLAEMIA 49 0.0051
552 GASTROENTERITIS 74 0.0051
553 EPILEPSY 155 0.0051
554 RHABDOMYOLYSIS 211 0.0051
555 FACIAL PARALYSIS 43 0.0050
556 SPINAL PAIN 59 0.0050
557 VITAMIN D DEFICIENCY 49 0.0050
558 BONE MARROW FAILURE 102 0.0050
559 LACERATION 47 0.0050
560 RHINITIS 40 0.0050
561 DIZZINESS POSTURAL 48 0.0049
562 NOCTURIA 60 0.0049
563 DYSARTHRIA 186 0.0049
564 URINARY INCONTINENCE 146 0.0049
565 PULMONARY MASS 73 0.0049
566 NEUROLEPTIC MALIGNANT SYNDROME 58 0.0049
567 PARALYSIS 70 0.0049
568 CEREBRAL INFARCTION 119 0.0049
569 HAEMORRHOIDS 95 0.0049
570 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 43 0.0049
571 ORAL CANDIDIASIS 64 0.0049
572 SKIN ULCER 125 0.0048
573 MALIGNANT NEOPLASM PROGRESSION 495 0.0048
574 BLOOD SODIUM DECREASED 91 0.0048
575 ATAXIA 57 0.0048
576 BLOOD CREATINE PHOSPHOKINASE INCREASED 138 0.0048
577 BURSITIS 58 0.0048
578 BLOOD PRESSURE SYSTOLIC INCREASED 93 0.0048
579 CHEST PAIN 883 0.0048
580 OSTEOARTHRITIS 202 0.0048
581 ROTATOR CUFF SYNDROME 61 0.0047
582 FALL 1573 0.0047
583 LACTIC ACIDOSIS 153 0.0047
584 TOOTH ABSCESS 48 0.0047
585 INTERVERTEBRAL DISC PROTRUSION 103 0.0047
586 LIVER FUNCTION TEST INCREASED 101 0.0047
587 BLOOD POTASSIUM DECREASED 141 0.0047
588 HYPOKINESIA 68 0.0047
589 ABDOMINAL PAIN LOWER 118 0.0047
590 HIP FRACTURE 150 0.0047
591 DYSPHAGIA 442 0.0047
592 HYPOPHAGIA 119 0.0047
593 RESPIRATORY DEPRESSION 57 0.0046
594 EXOSTOSIS 42 0.0046
595 GENERALISED TONIC-CLONIC SEIZURE 76 0.0046
596 MASS 64 0.0046
597 RIB FRACTURE 94 0.0046
598 URINARY TRACT INFECTION 775 0.0045
599 NEOPLASM 52 0.0045
600 LIVER INJURY 111 0.0045
601 MYOPATHY 39 0.0045
602 NEPHROPATHY 42 0.0045
603 BLOOD URINE PRESENT 85 0.0045
604 BODY TEMPERATURE DECREASED 44 0.0045
605 CEREBROVASCULAR ACCIDENT 756 0.0045
606 DISEASE PROGRESSION 528 0.0045
607 CHRONIC KIDNEY DISEASE 338 0.0044
608 DIALYSIS 63 0.0044
609 MUCOSAL INFLAMMATION 116 0.0044
610 DENTAL CARIES 49 0.0044
611 INTERSTITIAL LUNG DISEASE 214 0.0044
612 UNEVALUABLE EVENT 334 0.0044
613 ASTHENIA 1650 0.0044
614 HYPOTHYROIDISM 140 0.0044
615 EYE PAIN 247 0.0044
616 BREAST CANCER METASTATIC 47 0.0044
617 CONVULSION 250 0.0044
618 PROTEINURIA 83 0.0044
619 MYELODYSPLASTIC SYNDROME 63 0.0044
620 CLOSTRIDIUM DIFFICILE INFECTION 95 0.0043
621 DEPRESSED LEVEL OF CONSCIOUSNESS 172 0.0043
622 DYSPNOEA 2459 0.0043
623 BONE DISORDER 79 0.0043
624 OBSTRUCTIVE AIRWAYS DISORDER 48 0.0043
625 MUSCLE SPASTICITY 53 0.0043
626 CORONARY ARTERY OCCLUSION 59 0.0043
627 DYSURIA 158 0.0043
628 ANOREXIA 55 0.0043
629 ARRHYTHMIA 201 0.0042
630 ANGINA PECTORIS 121 0.0042
631 HYPOTONIA 42 0.0042
632 SCAR 72 0.0042
633 SPEECH DISORDER 220 0.0042
634 FAECES DISCOLOURED 91 0.0042
635 PREGNANCY 84 0.0042
636 DEVICE OCCLUSION 59 0.0042
637 BRONCHITIS 310 0.0042
638 BACTERIAL INFECTION 78 0.0042
639 RESPIRATORY ARREST 115 0.0042
640 PULMONARY FIBROSIS 80 0.0042
641 CYTOPENIA 51 0.0042
642 SKIN DISCOLOURATION 191 0.0042
643 HAEMATOCHEZIA 229 0.0041
644 LIGAMENT SPRAIN 41 0.0041
645 LETHARGY 238 0.0041
646 SENSORY DISTURBANCE 66 0.0041
647 ECZEMA 215 0.0041
648 VOMITING 1904 0.0040
649 BEDRIDDEN 53 0.0040
650 INFLAMMATION 208 0.0040
651 DECREASED APPETITE 936 0.0040
652 PLASMA CELL MYELOMA 157 0.0040
653 DRUG ERUPTION 71 0.0040
654 DIVERTICULITIS 111 0.0040
655 RESTLESSNESS 146 0.0040
656 PNEUMOCYSTIS JIROVECII PNEUMONIA 40 0.0040
657 BLOOD IRON DECREASED 47 0.0040
658 BLOOD POTASSIUM INCREASED 64 0.0039
659 VAGINAL HAEMORRHAGE 171 0.0039
660 PULMONARY ARTERIAL HYPERTENSION 57 0.0039
661 LOSS OF CONSCIOUSNESS 502 0.0039
662 NODULE 51 0.0039
663 NERVOUS SYSTEM DISORDER 121 0.0039
664 ANKLE FRACTURE 60 0.0039
665 HEPATIC ENZYME INCREASED 263 0.0039
666 PAIN IN JAW 109 0.0038
667 LOCAL SWELLING 67 0.0038
668 DIABETES MELLITUS INADEQUATE CONTROL 68 0.0038
669 NEUROPATHY PERIPHERAL 365 0.0038
670 PRODUCTIVE COUGH 183 0.0038
671 HEPATOTOXICITY 85 0.0038
672 RED BLOOD CELL SEDIMENTATION RATE INCREASED 42 0.0038
673 SKIN LESION 104 0.0038
674 PERIPHERAL COLDNESS 52 0.0038
675 SOMNOLENCE 762 0.0038
676 MEDICATION ERROR 210 0.0038
677 RASH MACULAR 132 0.0038
678 WHITE BLOOD CELL COUNT DECREASED 409 0.0038
679 PERITONITIS 78 0.0038
680 OSTEOPOROSIS 154 0.0037
681 PARAESTHESIA ORAL 54 0.0037
682 BACK PAIN 865 0.0037
683 UPPER RESPIRATORY TRACT INFECTION 172 0.0037
684 INTESTINAL OBSTRUCTION 140 0.0037
685 MYOCARDIAL INFARCTION 646 0.0037
686 EYELID OEDEMA 43 0.0037
687 NEOPLASM PROGRESSION 128 0.0037
688 BLOOD TRIGLYCERIDES INCREASED 65 0.0037
689 CHROMATURIA 83 0.0037
690 AGITATION 270 0.0037
691 HEART RATE IRREGULAR 83 0.0037
692 HYPERTENSION 773 0.0036
693 RESPIRATORY TRACT INFECTION 95 0.0036
694 INJECTION SITE HAEMORRHAGE 291 0.0036
695 SCIATICA 58 0.0036
696 GOUT 65 0.0036
697 DIARRHOEA 2332 0.0036
698 BLISTER 202 0.0036
699 GALLBLADDER DISORDER 64 0.0036
700 MUSCULAR WEAKNESS 406 0.0036
701 HEAD INJURY 113 0.0036
702 CONDITION AGGRAVATED 1082 0.0036
703 FISTULA 40 0.0036
704 INFECTION 515 0.0036
705 CYTOMEGALOVIRUS INFECTION 59 0.0035
706 ACTIVITIES OF DAILY LIVING IMPAIRED 70 0.0035
707 VASCULITIS 41 0.0035
708 PANCREATITIS 184 0.0035
709 SPINAL FRACTURE 69 0.0034
710 RASH PAPULAR 77 0.0034
711 TENDONITIS 53 0.0034
712 STOMATITIS 206 0.0034
713 GASTROOESOPHAGEAL REFLUX DISEASE 272 0.0034
714 HEPATIC FUNCTION ABNORMAL 125 0.0033
715 ERYTHEMA 687 0.0033
716 COUGH 933 0.0033
717 DRUG LEVEL INCREASED 55 0.0033
718 ABASIA 82 0.0033
719 INJECTION SITE INDURATION 43 0.0033
720 ORAL PAIN 74 0.0033
721 EYE HAEMORRHAGE 44 0.0033
722 BONE PAIN 192 0.0033
723 ABDOMINAL DISTENSION 342 0.0033
724 FRACTURE 62 0.0033
725 FOOT FRACTURE 62 0.0033
726 HIP ARTHROPLASTY 50 0.0033
727 INFUSION SITE PAIN 42 0.0033
728 BLOOD PRESSURE INCREASED 497 0.0032
729 DRUG TOXICITY 44 0.0032
730 RASH PRURITIC 175 0.0032
731 SWELLING 300 0.0032
732 LIMB INJURY 87 0.0032
733 NO THERAPEUTIC RESPONSE 39 0.0032
734 CONSTIPATION 695 0.0032
735 ANGIOEDEMA 139 0.0031
736 ANAPHYLACTIC SHOCK 81 0.0031
737 JOINT RANGE OF MOTION DECREASED 42 0.0031
738 DRUG-INDUCED LIVER INJURY 97 0.0031
739 HYPOAESTHESIA 462 0.0031
740 NAUSEA 2436 0.0031
741 BASAL CELL CARCINOMA 48 0.0031
742 BLOOD TEST ABNORMAL 43 0.0031
743 PAIN IN EXTREMITY 899 0.0030
744 OFF LABEL USE 2665 0.0030
745 MYDRIASIS 39 0.0030
746 HALLUCINATION 229 0.0030
747 PERICARDITIS 51 0.0030
748 VIRAL INFECTION 101 0.0030
749 FULL BLOOD COUNT DECREASED 61 0.0030
750 DEVICE FAILURE 46 0.0030
751 IMPAIRED GASTRIC EMPTYING 41 0.0030
752 LIVER DISORDER 133 0.0030
753 WEIGHT DECREASED 836 0.0030
754 PRODUCT PRESCRIBING ERROR 71 0.0030
755 RASH GENERALISED 77 0.0030
756 NEUROTOXICITY 52 0.0030
757 NEURALGIA 72 0.0030
758 ABDOMINAL PAIN UPPER 608 0.0030
759 COLON CANCER 44 0.0029
760 CYSTITIS 94 0.0029
761 HYPERHIDROSIS 376 0.0029
762 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 68 0.0029
763 EATING DISORDER 62 0.0029
764 SKIN HAEMORRHAGE 43 0.0029
765 TOOTHACHE 52 0.0029
766 ORAL HERPES 56 0.0029
767 LOWER LIMB FRACTURE 55 0.0029
768 HEART RATE INCREASED 283 0.0029
769 NO ADVERSE EVENT 512 0.0028
770 RESPIRATORY DISORDER 84 0.0028
771 MUSCULOSKELETAL PAIN 147 0.0028
772 CHEST DISCOMFORT 286 0.0028
773 SKIN DISORDER 93 0.0028
774 COVID-19 489 0.0028
775 COGNITIVE DISORDER 130 0.0028
776 COLD SWEAT 49 0.0028
777 EXTRAPYRAMIDAL DISORDER 69 0.0028
778 LOCALISED INFECTION 67 0.0028
779 FEEDING DISORDER 56 0.0028
780 RASH 1197 0.0027
781 ANXIETY 780 0.0027
782 TYPE 2 DIABETES MELLITUS 92 0.0027
783 COORDINATION ABNORMAL 38 0.0027
784 NECK PAIN 152 0.0027
785 DEMENTIA 76 0.0027
786 NIGHT SWEATS 87 0.0027
787 PRURITUS 1037 0.0027
788 ANAPHYLACTIC REACTION 149 0.0027
789 SKIN FISSURES 52 0.0027
790 EMOTIONAL DISTRESS 322 0.0027
791 MOUTH ULCERATION 56 0.0027
792 FUNGAL INFECTION 88 0.0026
793 MYALGIA 448 0.0026
794 TREATMENT NONCOMPLIANCE 144 0.0026
795 VERTIGO 160 0.0026
796 FATIGUE 2037 0.0026
797 PANCREATIC CARCINOMA 75 0.0026
798 LYMPHOMA 40 0.0026
799 ULCER 41 0.0026
800 WOUND 72 0.0026
801 JOINT INJURY 55 0.0026
802 DYSPEPSIA 253 0.0026
803 OSTEONECROSIS 84 0.0026
804 LUNG NEOPLASM MALIGNANT 104 0.0025
805 PAIN 1539 0.0025
806 PARAESTHESIA 394 0.0025
807 ACUTE MYELOID LEUKAEMIA 39 0.0025
808 DYSPHONIA 145 0.0025
809 RESTLESS LEGS SYNDROME 45 0.0025
810 SINUS DISORDER 49 0.0025
811 LABORATORY TEST ABNORMAL 73 0.0025
812 EAR PAIN 48 0.0025
813 PERIPHERAL SWELLING 380 0.0025
814 NEPHROLITHIASIS 113 0.0025
815 NEOPLASM MALIGNANT 162 0.0024
816 DIZZINESS 1206 0.0024
817 MOVEMENT DISORDER 77 0.0024
818 MENORRHAGIA 47 0.0024
819 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 41 0.0024
820 ARTHRALGIA 993 0.0024
821 CARDIAC DISORDER 223 0.0024
822 MOBILITY DECREASED 171 0.0024
823 CONTRAINDICATED PRODUCT ADMINISTERED 72 0.0024
824 PELVIC PAIN 43 0.0024
825 GAIT DISTURBANCE 448 0.0023
826 DERMATITIS 49 0.0023
827 FEELING COLD 65 0.0023
828 CARDIOVASCULAR DISORDER 59 0.0023
829 DIABETES MELLITUS 177 0.0023
830 VISION BLURRED 318 0.0023
831 TOOTH LOSS 48 0.0023
832 LIMB DISCOMFORT 71 0.0023
833 WHEEZING 136 0.0023
834 HEPATIC CIRRHOSIS 43 0.0023
835 TREMOR 379 0.0023
836 SURGERY 133 0.0023
837 FLUID RETENTION 115 0.0023
838 POLLAKIURIA 94 0.0023
839 BLOOD CHOLESTEROL INCREASED 105 0.0023
840 INSOMNIA 598 0.0022
841 SEIZURE 259 0.0022
842 LOWER RESPIRATORY TRACT INFECTION 101 0.0022
843 PRURITUS GENERALISED 48 0.0022
844 GASTROENTERITIS VIRAL 40 0.0022
845 ACCIDENTAL OVERDOSE 81 0.0022
846 INJECTION SITE PAIN 676 0.0022
847 ARTHROPATHY 122 0.0022
848 HEADACHE 1375 0.0022
849 SEROTONIN SYNDROME 42 0.0022
850 MALAISE 953 0.0022
851 DISTURBANCE IN ATTENTION 116 0.0021
852 URTICARIA 360 0.0021
853 DEPRESSION 486 0.0021
854 DIABETIC KETOACIDOSIS 51 0.0021
855 BALANCE DISORDER 179 0.0021
856 DYSKINESIA 84 0.0021
857 MUSCLE SPASMS 378 0.0021
858 AGGRESSION 103 0.0021
859 DEATH 1772 0.0021
860 AMNESIA 133 0.0020
861 KNEE ARTHROPLASTY 43 0.0020
862 FEELING HOT 125 0.0020
863 TOOTH DISORDER 45 0.0020
864 DISABILITY 40 0.0020
865 MENTAL DISORDER 88 0.0020
866 JOINT STIFFNESS 53 0.0020
867 VISUAL ACUITY REDUCED 67 0.0020
868 PALPITATIONS 236 0.0020
869 CATARACT 120 0.0020
870 SINUSITIS 206 0.0020
871 PRODUCT USE IN UNAPPROVED INDICATION 488 0.0020
872 BLOOD PRESSURE ABNORMAL 39 0.0020
873 SLEEP DISORDER 138 0.0020
874 DRUG ADMINISTRATION ERROR 60 0.0020
875 SWOLLEN TONGUE 61 0.0020
876 LIP SWELLING 65 0.0019
877 DRUG INTOLERANCE 186 0.0019
878 SWELLING FACE 125 0.0019
879 DEAFNESS 50 0.0019
880 INCORRECT DOSE ADMINISTERED BY DEVICE 50 0.0019
881 BURNING SENSATION 133 0.0019
882 HERPES ZOSTER 108 0.0019
883 PROCEDURAL PAIN 52 0.0019
884 SEDATION 49 0.0019
885 INJECTION SITE RASH 57 0.0019
886 DYSSTASIA 54 0.0018
887 EMOTIONAL DISORDER 57 0.0018
888 INJECTION SITE REACTION 127 0.0018
889 SKIN EXFOLIATION 155 0.0018
890 GLOSSODYNIA 41 0.0018
891 ARTHRITIS 144 0.0018
892 OROPHARYNGEAL PAIN 169 0.0018
893 HEART RATE DECREASED 64 0.0018
894 OVERDOSE 393 0.0018
895 HYPERSOMNIA 52 0.0018
896 HYPERSENSITIVITY 335 0.0018
897 INTENTIONAL PRODUCT USE ISSUE 158 0.0018
898 RENAL DISORDER 84 0.0018
899 ILL-DEFINED DISORDER 109 0.0018
900 BLOOD PRESSURE FLUCTUATION 43 0.0018
901 DYSGEUSIA 132 0.0018
902 FLATULENCE 100 0.0018
903 DISCOMFORT 107 0.0018
904 INFUSION RELATED REACTION 116 0.0017
905 ROAD TRAFFIC ACCIDENT 73 0.0017
906 GAIT INABILITY 58 0.0017
907 PSYCHOTIC DISORDER 50 0.0017
908 MUSCLE TWITCHING 39 0.0017
909 PAIN OF SKIN 45 0.0017
910 ABNORMAL BEHAVIOUR 66 0.0017
911 INCORRECT ROUTE OF DRUG ADMINISTRATION 59 0.0016
912 BLOOD GLUCOSE DECREASED 78 0.0016
913 INFLUENZA 180 0.0016
914 AGEUSIA 40 0.0016
915 GASTROINTESTINAL DISORDER 143 0.0016
916 ABDOMINAL DISCOMFORT 266 0.0016
917 NASAL CONGESTION 93 0.0016
918 RHINORRHOEA 102 0.0016
919 EXPIRED PRODUCT ADMINISTERED 52 0.0016
920 PANIC ATTACK 57 0.0016
921 DEVICE ISSUE 140 0.0016
922 WEIGHT INCREASED 346 0.0015
923 BLOOD GLUCOSE INCREASED 286 0.0015
924 PRODUCT USE ISSUE 285 0.0015
925 THROAT TIGHTNESS 41 0.0015
926 MIGRAINE 144 0.0015
927 INJECTION SITE SWELLING 115 0.0015
928 HOT FLUSH 113 0.0015
929 ASTHMA 168 0.0015
930 DRUG RESISTANCE 38 0.0015
931 DRY MOUTH 118 0.0015
932 HOSPITALISATION 222 0.0014
933 PRODUCT STORAGE ERROR 125 0.0014
934 MEMORY IMPAIRMENT 196 0.0014
935 BONE DENSITY DECREASED 44 0.0014
936 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
937 THERAPY NON-RESPONDER 63 0.0014
938 NERVOUSNESS 73 0.0014
939 DISEASE RECURRENCE 66 0.0014
940 JOINT SWELLING 166 0.0014
941 PRODUCT DOSE OMISSION 89 0.0014
942 FLUSHING 134 0.0013
943 MULTIPLE SCLEROSIS RELAPSE 90 0.0013
944 NASOPHARYNGITIS 241 0.0013
945 MUSCULOSKELETAL STIFFNESS 114 0.0013
946 SYSTEMIC LUPUS ERYTHEMATOSUS 46 0.0013
947 LACRIMATION INCREASED 39 0.0013
948 INFLUENZA LIKE ILLNESS 106 0.0013
949 VISUAL IMPAIRMENT 159 0.0013
950 COLITIS ULCERATIVE 56 0.0013
951 ALOPECIA 246 0.0013
952 DEVICE DISLOCATION 54 0.0012
953 INCORRECT DOSE ADMINISTERED 282 0.0012
954 HYPOACUSIS 53 0.0012
955 INJECTION SITE ERYTHEMA 152 0.0012
956 THERAPEUTIC RESPONSE DECREASED 73 0.0012
957 SUICIDE ATTEMPT 71 0.0012
958 UNDERDOSE 85 0.0012
959 NIGHTMARE 40 0.0012
960 ADVERSE EVENT 106 0.0011
961 THERAPY CESSATION 59 0.0011
962 DRUG DOSE OMISSION 188 0.0011
963 TOXICITY TO VARIOUS AGENTS 190 0.0011
964 DRY EYE 56 0.0011
965 PRODUCT QUALITY ISSUE 151 0.0011
966 DRY SKIN 146 0.0011
967 FEELING ABNORMAL 261 0.0011
968 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 77 0.0011
969 INJECTION SITE PRURITUS 72 0.0011
970 MULTIPLE SCLEROSIS 48 0.0010
971 ADVERSE DRUG REACTION 88 0.0010
972 DRUG INEFFECTIVE 1272 0.0010
973 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 46 0.0010
974 ILLNESS 98 0.0010
975 SUICIDAL IDEATION 83 0.0009
976 TREATMENT FAILURE 75 0.0009
977 DEVICE DIFFICULT TO USE 59 0.0009
978 INTENTIONAL OVERDOSE 57 0.0009
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 159 0.0009
980 ACCIDENTAL EXPOSURE TO PRODUCT 87 0.0008
981 PRODUCT SUBSTITUTION ISSUE 47 0.0008
982 PRODUCT DOSE OMISSION ISSUE 236 0.0008
983 THERAPY INTERRUPTED 55 0.0008
984 IRRITABILITY 45 0.0007
985 DEPRESSED MOOD 39 0.0007
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 133 0.0007
987 DRUG ABUSE 52 0.0006
988 ACNE 46 0.0006
989 INTENTIONAL PRODUCT MISUSE 53 0.0006
990 SKIN BURNING SENSATION 42 0.0006
991 PROSTATE CANCER 45 0.0006
992 RHEUMATOID ARTHRITIS 63 0.0006
993 PSORIASIS 69 0.0005
994 DRUG WITHDRAWAL SYNDROME 46 0.0005
995 BREAST CANCER 44 0.0005
996 DRUG DEPENDENCE 52 0.0003